Company profile
UK company 05732681, incorporated on 7 March 2006.
VivoSight Word leading medical imaging technology
Measure Morphologic and Angiographic Changes Visualize Skin Morphology to a Depth of > 1mm VivoSight DX visualise and quantify treatment effects for: Immune
Company number 05732681
Updated 07 Jul 2026 09:49
Financial period: 1 Oct 2023 to 30 Sep 2024
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Jul 2012 to 30 Jun 2013
Michelson Diagnostics is an independent UK start-up which has launched the world's first CEmarked, FDA-cleared OCT scanner for diagnosis & monitoring of non-melanoma skin cancer and other skin conditions. Our 'VivoSight' scanner is already being used in a small number of dermatology clinics in USA and Germany on a commercial basis and has the support of l...
1 Dec 2007 to 30 Nov 2009
Awaiting Public Summary
